Biotron's COVID-19 Trial Does Not Meet Nasal Viral Load Endpoint; Shares Plummet 36%
Biotron's COVID-19 Trial Does Not Meet Nasal Viral Load Endpoint; Shares Plummet 36%
Biotron的COVID-19試驗未達到鼻腔病毒載量的終點指標；股價暴跌36%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間